ZEB1, as an EMT enhancer and miR-200 transcriptional agent, relieves miR-200 suppression of PD-L1 on tumor cells, resulting in immunosuppression of CD8+  T cells and metastasis20. The gene discussed is CD8A; the disease is neoplasm.